Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
CVS Health Corporation (CVS)
Market Closed
15 Oct, 08:00 PM
NYSE
All
(15)
DE
(5)
AT
(1)
PE
(1)
CL
(2)
MX
(1)
IT
(2)
GB
(2)
US
(1)
NYSE
Primary
LSE
XMIL
XWBO
XSTU
XSGO
XETRA
XMUN
XDUS
XMEX
BVL
XSGO
XFRA
XMIL
CBOE
$
92.
58
+2.19
+2.4228%
After Hours
$
92.
84
+0.26
+0.2808%
112.03B
Market Cap
11.4
P/E Ratio
0.64%
Div Yield
12.41M
Volume
7.87
Eps
$
90.39
Previous Close
Investors:
TJD
DI
LC
+587
Watching
Watch
Add Transaction
Day Range
91
92.64
Year Range
69.51
110.68
Want to track
CVS
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
Investors
CVS Health Corporation (CVS) Statistics
Valuation metrics
Market Cap
112.03B
Enterprise value
174.91B
Trailing P/E (ttm)
22.5
Forward P/E
10.03
PEG ratio
3.52
Price/Sales (ttm)
0.26
Price/Book (mrq)
1.38
Enterprise Value/Revenue
0.42
Enterprise Value/EBITDA
13.04
Overview
Shares outstanding
1.27B
Float
1.27B
Shares short
18.35M
% Held by insiders
0%
% Held by institutions
0.9%
Average volume (10 days)
10.02M
Average volume (90 days)
8.69M
Price summary
52-Week low
69.51
52-Week high
110.68
Beta
0.59
50-Day moving average
87.91
200-Day moving average
89.52
Dividends and splits
Forward annual dividend rate
2.66
Forward annual dividend yield
0.0324%
Trailing annual dividend rate
2.66
Trailing annual dividend yield
0.0309%
5-Year annual dividend yield
3.22%
Payout ratio
0.7
Dividend Date
3 Aug 2026
Ex-Dividend Date
23 Jul 2026
Last split factor
2:1
Last split Date
7 Jun 2005
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.01%
Operating margin
0.02%
Operational effectiveness
Return on assets
0.02%
Return on equity
0.06%
Income Statement
Revenue (ttm)
399.83B
Revenue per share (ttm)
325.3
Quarterly revenue growth (yoy)
0.08%
Gross profit (ttm)
53.13B
EBITDA
15.1B
Net income to common (ttm)
1.77B
Diluted EPS (ttm)
3.84
Quarterly earnings growth (yoy)
0.79%
Balance Sheet
Total cash (mrq)
10.6B
Total cash per share (mrq)
10.94
Total debt (mrq)
79.95B
Total Debt/Equity (mrq)
0.96
Current ratio (mrq)
0.87%
Book value per share (mrq)
62.62
Cash Flow
Cash flow statement
10.64B
Levered free cash flow (LFCF)
5.93B